InvestorsHub Logo
Followers 29
Posts 1764
Boards Moderated 2
Alias Born 06/09/2005

Re: None

Sunday, 11/08/2015 9:27:57 PM

Sunday, November 08, 2015 9:27:57 PM

Post# of 48

MY UPDATE
The increase in shares was to settle some debt ,and the only one that they will do, Jim Holmes said no reason to increase shares in Lifeline .
They aren't doing any funding in llbo so will leave it alone "there will be no more issuance of shares!!" "i promise you"(jim holmes)
Cyrcadia raised and still raising money , currently at .50 cents share for the start of trials ,then again later for market entry for outside the United States,which should occur in Q1 - Q2 of 2016 ,and a final raise will be for entering the US market Q2 -Q3 the total raise for all those three events ,estimated is $12million .
right now cyrcadia has 21.5million shares ,llbo owns 8million,
When they raise money we will still have the 8 million shares ,maybe a smaller %but higher value (ill explain)plus royalty
Cyracdia should increase their shares around 15% to the raise money to get threw the trials , at first it seems bad but every time they raise money it will be for a higher price/next stage,the overall value will go up because of what they have achieved .
this isn't the type of dilution that decrease value ,its the opposite,
every time they raise money they will be raising the price because they will be in the later stages in the "game"
.Llbo still owns 8 million shares ,that will never change .50cents x 8million shares =$4million))right now)
the next raise will be at least $1- $2.50 a share when trials are done and applying for FDA/Ce regulatory markets
($1-2.50 x 8 million shares =$8million- $20million major value added, when they complete the trials and apply for both regulatory markets .
estimates for last round of raising cash for market entry outside USA 2.50-$5.00 a share x 8 million $20-40million
when they start sales oversees the estimated value of Cyrcadia shares will be at $5.00 a share .
when they are in both markets overseas and US, estimates are at $9-$11 a share x*8million plus royalty($72-$88million )(and that's probably the first year alone)
They are just finishing all the documentation for preparation for the testing to start first of June2016 .Allot of moving parts ,reason for delays ,so wouldn't be surprised for a week delay
the way the trials are set up ,they should last 4 -5 months months but could be longer or shorter .ill explain
A patient/women has mammogram if it indicates she needs a biopsy and before she does have it "we"ask her if she would take this Cyrcadia test that's strictly voluntary that will help detect cancer at a early stage ,and help women in the future etc.,they then wear the device for 12 hrs and get data.They have to test 173 women that's whats required by the FDA.could be 3 months or ,
could be 4-5 months .IMO i don't see many women saying no to a non invasive test .
500 patches will start being delivered the week of the May 26 ,will have 5 different sizes ,only to be worn for 12hrs not full 24 hrs like last set of test /trials .
trials being managed by Dr Farrar
-this is my D/D ,do your own Due Diligence.-
Replies:
Thank you!!
goldywang on 5/19/2015 10:38:28 AM
Great summary. Thanks
TBaggins on 5/19/2015 10:59:24 AM
Thanks for the update Change.
Ronin_Trader on 5/19/2015 11:30:51 AM
Thanks Change.
ACWprime on 5/19/2015 11:49:43 AM
sounds like a good place to be..but how
frodo66 on 5/19/2015 1:20:09 PM



Report TOS

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.